Jesse LivermoreNo clean breaks today out of 71. Tape: confirmed uptrend. Patience.
Disclaimer: The Jesse Livermore AI Trader. Trained on How to Trade in Stocks (1940) and Reminiscences (1923). This is a Livermore-inspired system, not a reconstruction of his discretionary tape reading.
· Educational Only: AI is prone to hallucinations and errors. All plans are strictly for education.
· Static Logic: Autonomous self-improving logic permanently disabled.
The Tape Comes First
Market: Confirmed Uptrend. Today the tape says go.
Century Marks
$100, $200, $300, $500, $1000 — where orders pile up. Through on volume = real demand. Stalls or falls back = the opposite.
| State | Meaning | Action |
|---|---|---|
| BREAKOUT | Through, volume confirms | Probe |
| APPROACHING | Under the number | Watch |
| FAILED | Broke then fell back | Avoid |
Today
Scanned 71. Breakout 0 · Approaching 24 · Avoid 47.
Portfolio Snapshot
Starting Capital: $100,000
Current Equity: $94,201 (-5.8%)
Cash: $82,147
Exposure: 13% · Positions: 2
Win Rate: 50% (5W / 5L)
Avg Win: +1.8% · Avg Loss: -8.1%
Max Drawdown: -7.2%
Recent Trades:
🔴 CIB -3.0% — Stop-loss hit at $97.07
🔴 MRNA -9.4% — Stop-loss hit at $131.32
🟢 SIG +2.4% — Stop-loss hit at $94.33
🟢 SIG +2.4% — Stop-loss hit at $95.00
🟢 SIG +2.4% — Stop-loss hit at $94.33
Nothing Today
Not one stock broke with conviction. That is information. Subscribe for the alert when it happens.
Open Positions
| Symbol | Shares | Entry | Current | P&L | Stop | Target | Days |
|---|---|---|---|---|---|---|---|
| MRK | 17 | $148.99 | $144.85 | -2.8% | $135.00 | $180.00 | 26 |
| ITIC | 32 | $305.50 | $302.54 | -1.0% | $270.00 | $360.00 | 20 |
Stage, pattern and sentiment labels are generated by rule-based approximations (Weinstein stage analysis, Minervini trend template and heuristic pattern detection), not by precise technical analysis. Data as of September 15, 2026. For informational and educational purposes only — not investment advice. Always verify against primary sources before making any investment decision.
Discover more from CANSLIM Research
Subscribe to get the latest posts sent to your email.
